About Vahe Bandarian
Form D filings for Sethera Therapeutics in 2024 list Vahe Bandarian as executive officer and director.
Vahe Bandarian first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Vahe Bandarian in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Vahe Bandarian works with at each company, as listed on that company's latest Form D.
Sethera Therapeutics, Inc · Form D, Oct 30, 2024
KE
Karsten Eastman
Chief Executive Officer and director
CT
Cynthia Tsai
Executive officer and director
YK
Yakov Kogan
Executive officer